Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein

[1]  Jianhui Gong,et al.  Correction of a pathogenic gene mutation in human embryos , 2017, Nature.

[2]  Hao Yin,et al.  Delivery technologies for genome editing , 2017, Nature Reviews Drug Discovery.

[3]  Z. Glass,et al.  Non-viral delivery of genome-editing nucleases for gene therapy , 2016, Gene Therapy.

[4]  K. Jensen,et al.  In vitro and ex vivo strategies for intracellular delivery , 2016, Nature.

[5]  Z. Dawei,et al.  A Novel Assay for Screening Inhibitors Targeting HIV Integrase LEDGF/p75 Interaction Based on Ni2+ Coated Magnetic Agarose Beads , 2016, Scientific Reports.

[6]  Z. Debyser,et al.  HIV-1 integrase inhibition: looking at cofactor interactions. , 2015, Future medicinal chemistry.

[7]  T. Rabbitts,et al.  Selection of human single domain antibodies recognizing the CMYC protein using enhanced intracellular antibody capture. , 2015, Journal of immunological methods.

[8]  R. Rathbun,et al.  The role of dolutegravir in the management of HIV infection , 2015, Infection and drug resistance.

[9]  M. Berkmen,et al.  Production of Disulfide‐Bonded Proteins in Escherichia coli , 2014, Current protocols in molecular biology.

[10]  S. Ekker,et al.  TALEN Knockout of the PSIP1 Gene in Human Cells: Analyses of HIV-1 Replication and Allosteric Integrase Inhibitor Mechanism , 2014, Journal of Virology.

[11]  S. Dübel,et al.  Delivery of antibodies to the cytosol , 2014, mAbs.

[12]  A. Marchand,et al.  LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 – 2014) , 2014, Expert opinion on therapeutic patents.

[13]  Xavier Robert,et al.  Deciphering key features in protein structures with the new ENDscript server , 2014, Nucleic Acids Res..

[14]  Marie-Paule Lefranc,et al.  Immunoglobulin and T Cell Receptor Genes: IMGT® and the Birth and Rise of Immunoinformatics , 2014, Front. Immunol..

[15]  E. Mancini,et al.  Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex , 2014, Scientific Reports.

[16]  Harry Jubb,et al.  Protein-protein interactions as druggable targets: recent technological advances. , 2013, Current opinion in pharmacology.

[17]  Kenneth L. Schaecher,et al.  The importance of treatment adherence in HIV. , 2013, The American journal of managed care.

[18]  Zeger Debyser,et al.  Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction. , 2013, Journal of medicinal chemistry.

[19]  Z. Debyser,et al.  The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy. , 2013, Virology.

[20]  M. Humbert,et al.  Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  M. Lei,et al.  The same pocket in menin binds both MLL and JUND but has opposite effects on transcription , 2012, Nature.

[22]  Soo-Yon Rhee,et al.  HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications , 2011, The Journal of infectious diseases.

[23]  M. Wainberg.  AIDS: Drugs that prevent HIV infection , 2011, Nature.

[24]  A. Marchand,et al.  Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. , 2010, Nature chemical biology.

[25]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[26]  R. Slany.  The molecular biology of mixed lineage leukemia , 2009, Haematologica.

[27]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[28]  Wulin Teo,et al.  An Essential Role for LEDGF/p75 in HIV Integration , 2006, Science.

[29]  C. Semple,et al.  Disruption of Ledgf/Psip1 Results in Perinatal Mortality and HomeoticSkeletal Transformations , 2006, Molecular and Cellular Biology.

[30]  Paul Shinn,et al.  A role for LEDGF/p75 in targeting HIV DNA integration , 2005, Nature Medicine.

[31]  A. Engelman,et al.  Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Engelman,et al.  Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75 , 2005, Nature Structural &Molecular Biology.

[33]  T. Rabbitts,et al.  Intracellular antibodies as specific reagents for functional ablation: future therapeutic molecules. , 2004, Current molecular medicine.

[34]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[35]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[36]  T. Rabbitts,et al.  Selection of antibodies for intracellular function using a two-hybrid in vivo system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[38]  A. Cattaneo,et al.  Intracellular immunization: antibody targeting to subcellular compartments. , 1995, Trends in cell biology.

[39]  B. Goldman,et al.  Debunking the myths. , 1990, Geriatric nursing.

[40]  Alexei Vagin,et al.  Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.

[41]  T. Rabbitts,et al.  Protocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture , 2010, Nature Protocols.

[42]  V. Giudicelli,et al.  IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. , 2003, Developmental and comparative immunology.

[43]  W. Marasco,et al.  Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. , 1997, Annual review of microbiology.

[44]  Fulvio Mavilio,et al.  Gene therapy , 1993, Nature.

[45]  D. Baltimore.  Gene therapy. Intracellular immunization. , 1988, Nature.